http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12857768

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 1870
issn 1535-7163
1538-8514
issueIdentifier 9
pageRange 1859-1870
publicationName Molecular Cancer Therapeutics
startingPage 1859
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fd9ee57179a15116ed6a560a15d30afd
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dcbd0e819edfe5623bf284071afca51e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d083af992003e7a623feba37e9508ff4
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9d50f771df3f48b6fe60af06e1790826
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2bb4658c80dbc0d82d9883ae789beb0a
bibliographicCitation Yang Y, Mamouni K, Li X, Chen Y, Kavuri S, Du Y, Fu H, Kucuk O, Wu D. Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer. Mol Cancer Ther. 2018 Sep;17(9):1859–70. PMID: 29907594; PMCID: PMC6125160.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bad84955ffdbe91fd4741abd4b921656
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd5f91b483971c2320383806f58edaf6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fead195e84305e4eeedc00d1a1fca58
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e11d5de60c5ef4e5e046d0091722eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d4b5936d7f7ff6af6efc9cc2d846b1b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c28f9d2cca549461f89050f5c4973fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0528f71ae4d6687f99cc0f2c1603d65a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89718696b7066523167e2669fd930250
date 2018-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1535-7163.mct-17-1176
https://pubmed.ncbi.nlm.nih.gov/PMC6125160
https://pubmed.ncbi.nlm.nih.gov/29907594
isPartOf https://portal.issn.org/resource/ISSN/1535-7163
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
https://portal.issn.org/resource/ISSN/1538-8514
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer
discusses http://id.nlm.nih.gov/mesh/M0027733
http://id.nlm.nih.gov/mesh/M0002948
http://id.nlm.nih.gov/mesh/M0026473
http://id.nlm.nih.gov/mesh/M0184558
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001859Q000188
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D011471Q000188
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D058492
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001859Q000378
http://id.nlm.nih.gov/mesh/D017448Q000819
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D059447Q000187
http://id.nlm.nih.gov/mesh/D011471Q000378
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011471Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D001971Q000008
http://id.nlm.nih.gov/mesh/D001859Q000556
http://id.nlm.nih.gov/mesh/D017448Q000378
http://id.nlm.nih.gov/mesh/D002470Q000187
http://id.nlm.nih.gov/mesh/D004357
http://id.nlm.nih.gov/mesh/D018491Q000008
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D000077143Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31101
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8b61580f3b0744d9098586a01c34cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8ec03999a28cdaaeb3c7910122bdd5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b30b0b608593935259123d48ab1a931d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a20a852de6e0b3ecac342b0499ddb5b
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42e5c8717e13ca9e92807498eccbf953
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_98035231fcaee69b50d4e6e928e41169
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2b3a5ba99bc94e77229bab735b7776f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6600c5cd2493e3a8f413e3b3388d00c7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9812d46bb63b7ca1d737789c0e1430b0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7826c784e8fc911de47e7fb31a96992f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6

Total number of triples: 85.